gefitinib has been researched along with tetramethylpyrazine in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (tetramethylpyrazine) | Trials (tetramethylpyrazine) | Recent Studies (post-2010) (tetramethylpyrazine) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 1,055 | 41 | 550 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelgawad, MA; Al-Sanea, MM; Alharbi, KS; Eldehna, WM; Elsayed, ZM; Gomaa, HAM; Gotina, L; Grace Thomas Parambi, D; Mathew, B; Mohamed, MF; Youssif, BGM | 1 |
1 other study(ies) available for gefitinib and tetramethylpyrazine
| Article | Year |
|---|---|
Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Gefitinib; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; HT29 Cells; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Pyrazines; Structure-Activity Relationship | 2020 |